Clinical Implications of Serum Albumin Levels in Acute Heart Failure: Insights from DOSE-AHF and ROSE-AHF
Highlights • Binding of albumin to diuretics are key to delivery to the nephron, and low albumin levels diminish intravascular oncotic pressures necessary to maintain intravascular volume for effective diuresis. • Based on prospectively collected data from two acute heart failure clinical trials (DO...
Gespeichert in:
| Veröffentlicht in: | Journal of cardiac failure 2016-11, Vol.22 (11), p.884-890 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 890 |
|---|---|
| container_issue | 11 |
| container_start_page | 884 |
| container_title | Journal of cardiac failure |
| container_volume | 22 |
| creator | Grodin, Justin L., MD Lala, Anuradha, MD Stevens, Susanna R., MS DeVore, Adam D., MD Cooper, Lauren B., MD AbouEzzedine, Omar F., MD CM Mentz, Robert J., MD Groarke, John D., MBBCh MPH Joyce, Emer, MBBCh Rosenthal, Julie L., MD Vader, Justin M., MD Tang, W.H. Wilson, MD |
| description | Highlights • Binding of albumin to diuretics are key to delivery to the nephron, and low albumin levels diminish intravascular oncotic pressures necessary to maintain intravascular volume for effective diuresis. • Based on prospectively collected data from two acute heart failure clinical trials (DOSE-AHF and ROSE-AHF), this may not be the case in acute heart failure populations largely free of nephrotic syndrome or cirrhosis. • Our data from two well characterized cohorts of patients with acute heart failure suggested serum albumin may not be a helpful tool to guide decongestion strategies or determine effectiveness of therapy. |
| doi_str_mv | 10.1016/j.cardfail.2016.01.015 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4970961</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1071916416000373</els_id><sourcerecordid>1826659321</sourcerecordid><originalsourceid>FETCH-LOGICAL-c592t-8a9dfdb6e113a55978ccc7db269495f0d7fd986a0c5d8b3cbffc8d6f7f4388203</originalsourceid><addsrcrecordid>eNqFUtFq2zAUNWNj7br9QtHjXpxJtizLeygLabMEAoVlexaydNUqk6VMsgP9-ykkLdteBhd0Lzr3HKFziuKa4BnBhH3azZSM2kjrZlWeZ5jkal4Vl6Spq5JTQl_nHrek7AijF8W7lHYYY05x-7a4qBintGX0srALZ71V0qH1sHe5GW3wCQWDthCnAc1dPw3Wow0cwCWUu7maRkArkHFEy6w_RfiM1j7Zh8cxIRPDgG7vt3flfLVE0mv07Ty8L94Y6RJ8OJ9XxY_l3ffFqtzcf10v5ptSNV01llx22uieASG1bJqu5UqpVvcV62jXGKxbozvOJFaN5n2temMU18y0htacV7i-Km5OvPupH0Ar8GOUTuyjHWR8EkFa8feNt4_iIRwE7VrcMZIJPp4JYvg1QRrFYJMC56SHMCVBeMVY09XVEcpOUBVDShHMiwzB4uiT2Ilnn8TRJ4FJriYvXv_5yJe1Z2My4MsJkH8dDhaiSMqCV6BtBDUKHez_NW7-oVBnr3_CE6RdmKLPRggiUiWw2B7TcgwLYTkodVvXvwEKzryK</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1826659321</pqid></control><display><type>article</type><title>Clinical Implications of Serum Albumin Levels in Acute Heart Failure: Insights from DOSE-AHF and ROSE-AHF</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Grodin, Justin L., MD ; Lala, Anuradha, MD ; Stevens, Susanna R., MS ; DeVore, Adam D., MD ; Cooper, Lauren B., MD ; AbouEzzedine, Omar F., MD CM ; Mentz, Robert J., MD ; Groarke, John D., MBBCh MPH ; Joyce, Emer, MBBCh ; Rosenthal, Julie L., MD ; Vader, Justin M., MD ; Tang, W.H. Wilson, MD</creator><creatorcontrib>Grodin, Justin L., MD ; Lala, Anuradha, MD ; Stevens, Susanna R., MS ; DeVore, Adam D., MD ; Cooper, Lauren B., MD ; AbouEzzedine, Omar F., MD CM ; Mentz, Robert J., MD ; Groarke, John D., MBBCh MPH ; Joyce, Emer, MBBCh ; Rosenthal, Julie L., MD ; Vader, Justin M., MD ; Tang, W.H. Wilson, MD</creatorcontrib><description>Highlights • Binding of albumin to diuretics are key to delivery to the nephron, and low albumin levels diminish intravascular oncotic pressures necessary to maintain intravascular volume for effective diuresis. • Based on prospectively collected data from two acute heart failure clinical trials (DOSE-AHF and ROSE-AHF), this may not be the case in acute heart failure populations largely free of nephrotic syndrome or cirrhosis. • Our data from two well characterized cohorts of patients with acute heart failure suggested serum albumin may not be a helpful tool to guide decongestion strategies or determine effectiveness of therapy.</description><identifier>ISSN: 1071-9164</identifier><identifier>EISSN: 1532-8414</identifier><identifier>DOI: 10.1016/j.cardfail.2016.01.015</identifier><identifier>PMID: 26844764</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Acute Disease ; Aged ; Biomarkers - blood ; Cardiovascular ; Cause of Death ; Chi-Square Distribution ; diuretics ; Diuretics - therapeutic use ; Double-Blind Method ; Female ; Heart failure ; Heart Failure - blood ; Heart Failure - drug therapy ; Heart Failure - mortality ; Heart Failure - physiopathology ; Hospital Mortality ; Humans ; Kidney Function Tests ; Logistic Models ; Male ; Middle Aged ; Prognosis ; Proportional Hazards Models ; Prospective Studies ; proteins ; Randomized Controlled Trials as Topic ; Renal Insufficiency - drug therapy ; Renal Insufficiency - mortality ; Renal Insufficiency - physiopathology ; Risk Assessment ; Serum Albumin - analysis ; Severity of Illness Index ; Survival Analysis ; United States</subject><ispartof>Journal of cardiac failure, 2016-11, Vol.22 (11), p.884-890</ispartof><rights>2016 Elsevier Inc.</rights><rights>Copyright © 2016 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c592t-8a9dfdb6e113a55978ccc7db269495f0d7fd986a0c5d8b3cbffc8d6f7f4388203</citedby><cites>FETCH-LOGICAL-c592t-8a9dfdb6e113a55978ccc7db269495f0d7fd986a0c5d8b3cbffc8d6f7f4388203</cites><orcidid>0000-0002-8335-735X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1071916416000373$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26844764$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Grodin, Justin L., MD</creatorcontrib><creatorcontrib>Lala, Anuradha, MD</creatorcontrib><creatorcontrib>Stevens, Susanna R., MS</creatorcontrib><creatorcontrib>DeVore, Adam D., MD</creatorcontrib><creatorcontrib>Cooper, Lauren B., MD</creatorcontrib><creatorcontrib>AbouEzzedine, Omar F., MD CM</creatorcontrib><creatorcontrib>Mentz, Robert J., MD</creatorcontrib><creatorcontrib>Groarke, John D., MBBCh MPH</creatorcontrib><creatorcontrib>Joyce, Emer, MBBCh</creatorcontrib><creatorcontrib>Rosenthal, Julie L., MD</creatorcontrib><creatorcontrib>Vader, Justin M., MD</creatorcontrib><creatorcontrib>Tang, W.H. Wilson, MD</creatorcontrib><title>Clinical Implications of Serum Albumin Levels in Acute Heart Failure: Insights from DOSE-AHF and ROSE-AHF</title><title>Journal of cardiac failure</title><addtitle>J Card Fail</addtitle><description>Highlights • Binding of albumin to diuretics are key to delivery to the nephron, and low albumin levels diminish intravascular oncotic pressures necessary to maintain intravascular volume for effective diuresis. • Based on prospectively collected data from two acute heart failure clinical trials (DOSE-AHF and ROSE-AHF), this may not be the case in acute heart failure populations largely free of nephrotic syndrome or cirrhosis. • Our data from two well characterized cohorts of patients with acute heart failure suggested serum albumin may not be a helpful tool to guide decongestion strategies or determine effectiveness of therapy.</description><subject>Acute Disease</subject><subject>Aged</subject><subject>Biomarkers - blood</subject><subject>Cardiovascular</subject><subject>Cause of Death</subject><subject>Chi-Square Distribution</subject><subject>diuretics</subject><subject>Diuretics - therapeutic use</subject><subject>Double-Blind Method</subject><subject>Female</subject><subject>Heart failure</subject><subject>Heart Failure - blood</subject><subject>Heart Failure - drug therapy</subject><subject>Heart Failure - mortality</subject><subject>Heart Failure - physiopathology</subject><subject>Hospital Mortality</subject><subject>Humans</subject><subject>Kidney Function Tests</subject><subject>Logistic Models</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Prognosis</subject><subject>Proportional Hazards Models</subject><subject>Prospective Studies</subject><subject>proteins</subject><subject>Randomized Controlled Trials as Topic</subject><subject>Renal Insufficiency - drug therapy</subject><subject>Renal Insufficiency - mortality</subject><subject>Renal Insufficiency - physiopathology</subject><subject>Risk Assessment</subject><subject>Serum Albumin - analysis</subject><subject>Severity of Illness Index</subject><subject>Survival Analysis</subject><subject>United States</subject><issn>1071-9164</issn><issn>1532-8414</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFUtFq2zAUNWNj7br9QtHjXpxJtizLeygLabMEAoVlexaydNUqk6VMsgP9-ykkLdteBhd0Lzr3HKFziuKa4BnBhH3azZSM2kjrZlWeZ5jkal4Vl6Spq5JTQl_nHrek7AijF8W7lHYYY05x-7a4qBintGX0srALZ71V0qH1sHe5GW3wCQWDthCnAc1dPw3Wow0cwCWUu7maRkArkHFEy6w_RfiM1j7Zh8cxIRPDgG7vt3flfLVE0mv07Ty8L94Y6RJ8OJ9XxY_l3ffFqtzcf10v5ptSNV01llx22uieASG1bJqu5UqpVvcV62jXGKxbozvOJFaN5n2temMU18y0htacV7i-Km5OvPupH0Ar8GOUTuyjHWR8EkFa8feNt4_iIRwE7VrcMZIJPp4JYvg1QRrFYJMC56SHMCVBeMVY09XVEcpOUBVDShHMiwzB4uiT2Ilnn8TRJ4FJriYvXv_5yJe1Z2My4MsJkH8dDhaiSMqCV6BtBDUKHez_NW7-oVBnr3_CE6RdmKLPRggiUiWw2B7TcgwLYTkodVvXvwEKzryK</recordid><startdate>20161101</startdate><enddate>20161101</enddate><creator>Grodin, Justin L., MD</creator><creator>Lala, Anuradha, MD</creator><creator>Stevens, Susanna R., MS</creator><creator>DeVore, Adam D., MD</creator><creator>Cooper, Lauren B., MD</creator><creator>AbouEzzedine, Omar F., MD CM</creator><creator>Mentz, Robert J., MD</creator><creator>Groarke, John D., MBBCh MPH</creator><creator>Joyce, Emer, MBBCh</creator><creator>Rosenthal, Julie L., MD</creator><creator>Vader, Justin M., MD</creator><creator>Tang, W.H. Wilson, MD</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-8335-735X</orcidid></search><sort><creationdate>20161101</creationdate><title>Clinical Implications of Serum Albumin Levels in Acute Heart Failure: Insights from DOSE-AHF and ROSE-AHF</title><author>Grodin, Justin L., MD ; Lala, Anuradha, MD ; Stevens, Susanna R., MS ; DeVore, Adam D., MD ; Cooper, Lauren B., MD ; AbouEzzedine, Omar F., MD CM ; Mentz, Robert J., MD ; Groarke, John D., MBBCh MPH ; Joyce, Emer, MBBCh ; Rosenthal, Julie L., MD ; Vader, Justin M., MD ; Tang, W.H. Wilson, MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c592t-8a9dfdb6e113a55978ccc7db269495f0d7fd986a0c5d8b3cbffc8d6f7f4388203</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Acute Disease</topic><topic>Aged</topic><topic>Biomarkers - blood</topic><topic>Cardiovascular</topic><topic>Cause of Death</topic><topic>Chi-Square Distribution</topic><topic>diuretics</topic><topic>Diuretics - therapeutic use</topic><topic>Double-Blind Method</topic><topic>Female</topic><topic>Heart failure</topic><topic>Heart Failure - blood</topic><topic>Heart Failure - drug therapy</topic><topic>Heart Failure - mortality</topic><topic>Heart Failure - physiopathology</topic><topic>Hospital Mortality</topic><topic>Humans</topic><topic>Kidney Function Tests</topic><topic>Logistic Models</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Prognosis</topic><topic>Proportional Hazards Models</topic><topic>Prospective Studies</topic><topic>proteins</topic><topic>Randomized Controlled Trials as Topic</topic><topic>Renal Insufficiency - drug therapy</topic><topic>Renal Insufficiency - mortality</topic><topic>Renal Insufficiency - physiopathology</topic><topic>Risk Assessment</topic><topic>Serum Albumin - analysis</topic><topic>Severity of Illness Index</topic><topic>Survival Analysis</topic><topic>United States</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Grodin, Justin L., MD</creatorcontrib><creatorcontrib>Lala, Anuradha, MD</creatorcontrib><creatorcontrib>Stevens, Susanna R., MS</creatorcontrib><creatorcontrib>DeVore, Adam D., MD</creatorcontrib><creatorcontrib>Cooper, Lauren B., MD</creatorcontrib><creatorcontrib>AbouEzzedine, Omar F., MD CM</creatorcontrib><creatorcontrib>Mentz, Robert J., MD</creatorcontrib><creatorcontrib>Groarke, John D., MBBCh MPH</creatorcontrib><creatorcontrib>Joyce, Emer, MBBCh</creatorcontrib><creatorcontrib>Rosenthal, Julie L., MD</creatorcontrib><creatorcontrib>Vader, Justin M., MD</creatorcontrib><creatorcontrib>Tang, W.H. Wilson, MD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of cardiac failure</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Grodin, Justin L., MD</au><au>Lala, Anuradha, MD</au><au>Stevens, Susanna R., MS</au><au>DeVore, Adam D., MD</au><au>Cooper, Lauren B., MD</au><au>AbouEzzedine, Omar F., MD CM</au><au>Mentz, Robert J., MD</au><au>Groarke, John D., MBBCh MPH</au><au>Joyce, Emer, MBBCh</au><au>Rosenthal, Julie L., MD</au><au>Vader, Justin M., MD</au><au>Tang, W.H. Wilson, MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical Implications of Serum Albumin Levels in Acute Heart Failure: Insights from DOSE-AHF and ROSE-AHF</atitle><jtitle>Journal of cardiac failure</jtitle><addtitle>J Card Fail</addtitle><date>2016-11-01</date><risdate>2016</risdate><volume>22</volume><issue>11</issue><spage>884</spage><epage>890</epage><pages>884-890</pages><issn>1071-9164</issn><eissn>1532-8414</eissn><abstract>Highlights • Binding of albumin to diuretics are key to delivery to the nephron, and low albumin levels diminish intravascular oncotic pressures necessary to maintain intravascular volume for effective diuresis. • Based on prospectively collected data from two acute heart failure clinical trials (DOSE-AHF and ROSE-AHF), this may not be the case in acute heart failure populations largely free of nephrotic syndrome or cirrhosis. • Our data from two well characterized cohorts of patients with acute heart failure suggested serum albumin may not be a helpful tool to guide decongestion strategies or determine effectiveness of therapy.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>26844764</pmid><doi>10.1016/j.cardfail.2016.01.015</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-8335-735X</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1071-9164 |
| ispartof | Journal of cardiac failure, 2016-11, Vol.22 (11), p.884-890 |
| issn | 1071-9164 1532-8414 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4970961 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Acute Disease Aged Biomarkers - blood Cardiovascular Cause of Death Chi-Square Distribution diuretics Diuretics - therapeutic use Double-Blind Method Female Heart failure Heart Failure - blood Heart Failure - drug therapy Heart Failure - mortality Heart Failure - physiopathology Hospital Mortality Humans Kidney Function Tests Logistic Models Male Middle Aged Prognosis Proportional Hazards Models Prospective Studies proteins Randomized Controlled Trials as Topic Renal Insufficiency - drug therapy Renal Insufficiency - mortality Renal Insufficiency - physiopathology Risk Assessment Serum Albumin - analysis Severity of Illness Index Survival Analysis United States |
| title | Clinical Implications of Serum Albumin Levels in Acute Heart Failure: Insights from DOSE-AHF and ROSE-AHF |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T07%3A11%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20Implications%20of%20Serum%20Albumin%20Levels%20in%20Acute%20Heart%20Failure:%20Insights%20from%20DOSE-AHF%20and%20ROSE-AHF&rft.jtitle=Journal%20of%20cardiac%20failure&rft.au=Grodin,%20Justin%20L.,%20MD&rft.date=2016-11-01&rft.volume=22&rft.issue=11&rft.spage=884&rft.epage=890&rft.pages=884-890&rft.issn=1071-9164&rft.eissn=1532-8414&rft_id=info:doi/10.1016/j.cardfail.2016.01.015&rft_dat=%3Cproquest_pubme%3E1826659321%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1826659321&rft_id=info:pmid/26844764&rft_els_id=S1071916416000373&rfr_iscdi=true |